Brief: Simcere Pharmaceutical Posts Profit For Year Attributable RMB933 Million

Simcere Pharmaceutical

31/03/2023 16:11

March 31 (Reuters) - Simcere Pharmaceutical Group Ltd
 2096.HK :
    * PROFIT FOR YEAR ATTRIBUTABLE RMB933 MILLION, DECREASE OF
38.1%
    * FY REVENUE RMB6,319 MILLION, INCREASE OF 26.4%
    * DECLARED PAYMENT OF FINAL DIVIDEND OF RMB0.16 PER SHARE
    * PREDICT THAT 2023 WILL STILL BE A YEAR OF NEWLY-LAUNCHED
PRODUCTS

Surce text for Eikon:  ID: 
Further company coverage:  2096.HK